Astera Labs financials
$357.84+1.86%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $392.4M | $308.4M | $270.6M | $230.6M | $191.9M | $159.4M | $141.1M | $113.1M | $76.8M | $65.3M |
| Gross profit | $287.6M | $235.1M | $204.5M | $175.8M | $145.6M | $119.4M | $104.4M | $87.9M | $59.9M | $50.5M |
| Gross margin | 73.3% | 76.3% | 75.6% | 76.2% | 75.8% | 74.9% | 74.0% | 77.7% | 77.9% | 77.4% |
| Operating income | $89.2M | $61.8M | $67.0M | $55.4M | $39.8M | $11.3M | $144.0K | -$8.9M | -$24.3M | -$83.0M |
| Net income | $153.1M | $80.3M | $45.0M | $91.1M | $51.2M | $31.8M | $24.7M | -$7.6M | -$7.5M | -$93.0M |
| Net margin | 39.0% | 26.0% | 16.6% | 39.5% | 26.7% | 20.0% | 17.5% | −6.7% | −9.8% | −142.5% |
| Diluted EPS | $0.83 | $0.44 | $0.25 | $0.50 | $0.29 | $0.18 | $0.15 | $-0.05 | $-0.05 | $-1.77 |
| EBITDA | $93.2M | $65.5M | $69.8M | $56.9M | $41.2M | $12.4M | $1.1M | -$8.0M | -$23.6M | -$82.4M |
| Operating cash flow | $87.7M | $74.6M | $95.3M | $78.2M | $135.4M | $10.5M | $39.7M | $63.5M | $29.8M | $3.7M |
| Free cash flow | $67.2M | $67.0M | $76.6M | $65.9M | $133.3M | $6.0M | $24.3M | $46.8M | $28.5M | $228.0K |
| Diluted shares | 183.3M | 181.2M | 181.4M | 180.6M | 178.1M | 178.1M | 160.5M | 156.8M | 155.2M | 52.5M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $111.5M | $148.3M | $167.6M | $140.4M | $162.3M | $86.4M |
| Short-term investments | $1.14B | $1.04B | $1.02B | $994.0M | $902.8M | $838.3M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $1.93B | $1.66B | $1.53B | $1.40B | $1.27B | $1.12B |
| Total liabilities | $205.8M | $165.3M | $168.2M | $129.5M | $135.7M | $80.1M |
| Shareholders' equity | $1.73B | $1.49B | $1.36B | $1.27B | $1.14B | $1.04B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology